The present invention is directed to novel fused pyrrolocarbazoles and
isoindolones, including pharmaceutical compositions, diagnostic kits,
assay standards or reagents containing the same, and methods of using the
same as therapeutics. The invention is also directed to intermediates and
processes for making these novel compounds.